Locke Planning Board schedules public hearing for minor subdivision review

Aileen McNabb-Coleman, Cayuga County
Aileen McNabb-Coleman, Cayuga County
0Comments

The town of Locke Planning Board announced on Mar. 18 that it will hold a public hearing on Tuesday, April 7 at 7:00 p.m. The meeting will take place at the Locke Town Hall and Justice Center, located at 1215 State Route 38 in Locke, New York.

The purpose of the hearing is to review and approve a proposed minor subdivision for Sarah Frakes at the property identified as 222.00-1-5 Masten Road in Locke.

Public hearings such as this allow community members to provide input and ensure transparency in local land use decisions. The process gives residents an opportunity to learn more about proposed changes and voice any concerns or support they may have regarding development projects.

No additional background information or further details about the subdivision were provided in the announcement.

Residents interested in participating are encouraged to attend the meeting at the scheduled time and location.



Related

Aileen McNabb-Coleman, Cayuga County

Cayuga County seeks consultant bids for housing market study

Cayuga County has issued a request for proposals seeking consultant services for a housing market study. Bids are due by May 13, with questions accepted until April 30. The results will help guide future planning decisions.

William G. Devine, Town Supervisor, Groveland at Livingston County

Prince family receives 2026 Earth Day Award from Environmental Management Council

Jonathan and Jennifer Prince received this year’s Earth Day Award from Livingston County’s Environmental Management Council for their stewardship of historic land in Groveland. The family’s commitment includes maintaining conservation easements that protect local open spaces and waterways.

Sara Brenner, Principal Deputy Commissioner at FDA

Yates County cities: 1 company received an FDA inspection in March

There was one company in a city associated with Yates County that received an FDA inspection in March, according to the U.S. Food and Drug Administration.